Success Story: Our Firm Assisted a Pakistani Postdoctoral Fellow in Securing NIW Approval

Client’s Testimonial:

“I will be honest in providing genuine feedback. I was not expecting the smooth and very convenient services provided by Chen Immigration. Especially my attorney was very nice and active during the whole application process. I really appreciate it and am very satisfied with availing of the Chen immigration services for my EB-2 NIW application. Moreover, I will recommend wegreened.com to all people in my circle and to those who would be needed.”

On January 23^rd, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Fellow in the Field of Organic Synthesis (Approval Notice).

General Field: Organic Synthesis

Position at the Time of Case Filing: Postdoctoral Fellow

Country of Origin: Pakistan

Country of Residence at the Time of Filing: South Korea

Approval Notice Date: January 23^rd, 2025

Processing Time: 9 months, 8 days

Case Summary:

It was our pleasure to support a chemical engineering specialist, who holds a Ph.D. in the field, in securing approval for an EB-2 NIW petition. As with every case, our team carefully reviewed the client’s academic and professional background and constructed a petition tailored to highlight the strengths of the profile.

The client’s proposed endeavor centers on advancing sustainable organic synthesis by developing environmentally friendly protocols and designing polyaromatic hydrocarbons (PAHs) to serve as alternatives to traditional metal-based chromophores. These materials are aimed at use in solar cells and organic light-emitting diodes (OLEDs), with the goal of commercializing them for broader applications. In addition, the client seeks to incorporate extended reality tools such as augmented reality (AR), virtual reality (VR), and metaverse platforms into scientific research and chemistry education, creating new opportunities for both innovation and pedagogy.

We established the importance of this research by showing how it addresses pressing challenges in renewable energy, sustainability, and technology-enhanced learning. The contributions not only support energy security and clean technologies but also open new pathways for training the next generation of scientists through immersive and interactive learning models.

The client’s research record reflects strong achievements in the field: 7 peer-reviewed journal articles, 4 of them first- or sole-authored. This body of work has accumulated 184 citations, underscoring its relevance and influence among peers in organic synthesis and related disciplines. Beyond publications, the client has benefited from major funding awards, including support from the National Research Foundation of Korea and the Ministry of Science and ICT of Korea, which further demonstrates international recognition of the value of this research.

To complement the documentary evidence, the petition included 2 detailed recommendation letters from independent experts in the field. These letters spoke to the originality, importance, and impact of the client’s work while affirming the strong potential for continued contributions.

“I shall make it clear in this letter that [Client] represents an invaluable asset that must be retained within the United States.”

With this evidence, USCIS approved the NIW petition, confirming the importance of the client’s contributions to U.S. national interests. It has been an honor to work alongside such a dedicated researcher, and we look forward to seeing the continuing impact of this innovative work on both science and society.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.